These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12375796)

  • 1. Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer.
    Wu HG; Choy H
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):13-8. PubMed ID: 12375796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irinotecan in combined-modality therapy for locally advanced non-small-cell lung cancer.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):31-6. PubMed ID: 11221019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.
    Choy H; Chakravarthy A; Devore RF; Jagasia M; Hande KR; Roberts JR; Johnson DH; Yunus F
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):43-6. PubMed ID: 10981290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topoisomerase I inhibitors in the combined-modality therapy of lung cancer.
    Cho LC; Choy H
    Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):29-39. PubMed ID: 15255165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irinotecan and radiation in combined-modality therapy for solid tumors.
    Choy H; MacRae R
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):22-8. PubMed ID: 11497228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of irinotecan in lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):6-7. PubMed ID: 11221022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irinotecan hydrochloride (CPT-11)].
    Furue H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irinotecan therapy for small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current role of irinotecan in the treatment of non-small-cell lung cancer.
    Kelly K
    Oncology (Williston Park); 2002 Sep; 16(9):1153-62, 1165; discussion 1165-6 passim. PubMed ID: 12380945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan in small-cell lung cancer--Japanese trials.
    Fukuoka M; Masuda N; Kudoh S; Negoro S
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):57-62. PubMed ID: 10981292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer.
    Takeda K; Negoro S; Kudoh S; Okishio K; Masuda N; Takada M; Tanaka M; Nakajima T; Tada T; Fukuoka M
    Br J Cancer; 1999 Mar; 79(9-10):1462-7. PubMed ID: 10188891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel and irinotecan, alone and in combination, in the treatment of non-small cell lung cancer.
    Adjei AA; Argiris A; Murren JR
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):32-40; discussion 41-2. PubMed ID: 10585007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging world role of irinotecan in lung cancer.
    Langer CJ
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):15-21. PubMed ID: 11497227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of topoisomerase I inhibitors in small-cell lung cancer.
    Fukuoka M
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical and clinical trials of topoisomerase inhibitors.
    Saijo N
    Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan plus cisplatin in small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):39-43. PubMed ID: 12375800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irinotecan in the treatment of small cell lung cancer.
    Masuda N; Fukuoka M
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):187-95. PubMed ID: 12113024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor radio-response by irinotecan in human lung tumor xenografts.
    Tamura K; Takada M; Kawase I; Tada T; Kudoh S; Okishio K; Fukuoka M; Yamaoka N; Fujiwara Y; Yamakido M
    Jpn J Cancer Res; 1997 Feb; 88(2):218-23. PubMed ID: 9119752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irinotecan in small-cell lung cancer: the US experience.
    Sandler AB
    Oncology (Williston Park); 2001 Jan; 15(1 Suppl 1):11-2. PubMed ID: 11221015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irinotecan].
    Yokoyama A
    Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.